Loading clinical trials...
Loading clinical trials...
A Phase 4, Single Center, Open Label Study Evaluating the Safety of the Nasal Guide Utilized During Administration With Tyrvaya
Conditions
Interventions
Nasal Guide
Locations
2
United States
United States, New Jersey
Edison, New Jersey, United States
United States, New Jersey
Woodland Park, New Jersey, United States
Start Date
June 14, 2023
Primary Completion Date
August 18, 2023
Completion Date
August 18, 2023
Last Updated
May 6, 2025
NCT07463950
NCT07363824
NCT07396441
NCT05865379
NCT05865457
NCT07366944
Lead Sponsor
Oyster Point Pharma, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions